Gemphire Therapeutics Inc. (GEMP) Declined -5.56% or -0.36 To Price $6.12 On Wednesday


Gemphire Therapeutics Inc. (GEMP) declined -5.56% or -0.36 to $6.12. It is nearly 44494 shares traded, which is 46.47% compare to the average total volume 95758. The market cap of GEMP is $87.06 million. The year to date change is -17.45%. The 52 week price range is from $5.87 to $21.59. Price of GEMP have changed 0.62% during last week. It have changed -14.62% over last month, -12.90% over last 3 months, -37.21% over last 6 months and -42.91% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for GEMP is 7.27. It is 18.79% above current price. The 200-day Moving Averages for GEMP is 9.59. It is 56.70% above current price. The 52-week High is 21.59. It is 252.78% from the current price. The 52-week Low is 5.87. It is -4.08% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of GEMP is 2.32 on 2018-03-15. Short % to float is 3.04%. There are some statistics of GEMP. It is has market cap $87.06 million. The share outstanding is 14.23 million. The average volume is 95758. The percent of top 15 Institution holding is 35.00%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of GEMP is -271.97%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of GEMP is -152.68%.


Tags:

Share this post